DB15420InvestigationalProtein Based Therapies
Coagulation factor XIa is under investigation in clinical trial NCT01701947 (HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency).
- Also known as
- Human coagulation factor XI
Resolves to
Compound
What you can answer from here — as of April 02, 2025
Which companies are running trials of Coagulation factor XIa, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account